Atossa Genetics (ATOS) Reports Q2 Loss of $0.11

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.11), versus ($0.13) reported last year. Revenue for the quarter came in at $2.69 million versus the consensus estimate of $9.9 thousand.

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Crocs upgraded to Overweight at Piper Sandler on North America recovery signs
• Kite Realty sells City Center in White Plains for $50 million